Source:http://linkedlifedata.com/resource/pubmed/id/11292549
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2001-4-9
|
pubmed:abstractText |
The solubilities in isopropyl myristate (SIPM) and pH 4.0 buffer (SAQ) and the partition coefficients between IPM and pH 4.0 buffer (KIPM:AQ) have been measured for a series of 3-alkylcarbonyl-5-fluorouracil prodrugs (3-AC-5-FU). The 3-AC-5-FU prodrugs were all 100 times more soluble in IPM and the first two members of the series were also more soluble in pH 4.0 buffer than 5-FU. The abilities of the 3-AC-5-FU prodrugs to deliver total 5-FU species through hairless mouse skin from IPM suspensions (Ji) were also measured. The 3-propionyl derivative 3, which exhibited the highest SAQ in the series, gave the highest Ji value. The SIPM, SAQ and molecular weights (mw) of the 3-AC-5-FU series correctly predicted the rank order and very closely (0.10 log units) predicted the absolute values for logJi using the transformed Potts-Guy equation. Although the series of 3-AC-5-FU prodrugs was generally quite effective at increasing Ji (2-20 times), the best 3-AC-5-FU prodrug was not as effective as the best 1-alkylcarbonyl-5-FU prodrug (1-AC-5-FU) at increasing Ji and the ability of the 3-AC-5-FU prodrugs to increase the concentration of total 5-FU species in the skin was 2-5 times less than the 1-AC-5-FU prodrugs. Thus, the 1-AC-5-FU prodrugs remain as the best prodrugs with which to enhance the topical delivery of 5-FU.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0378-5173
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
217
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
127-37
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11292549-Administration, Topical,
pubmed-meshheading:11292549-Animals,
pubmed-meshheading:11292549-Antimetabolites, Antineoplastic,
pubmed-meshheading:11292549-Diffusion,
pubmed-meshheading:11292549-Female,
pubmed-meshheading:11292549-Fluorouracil,
pubmed-meshheading:11292549-Mice,
pubmed-meshheading:11292549-Mice, Hairless,
pubmed-meshheading:11292549-Permeability,
pubmed-meshheading:11292549-Prodrugs,
pubmed-meshheading:11292549-Skin
|
pubmed:year |
2001
|
pubmed:articleTitle |
Topical delivery of 5-fluorouracil (5-Fu) by 3-alkylcarbonyl-5-Fu prodrugs.
|
pubmed:affiliation |
Department of Pharmaceutical Sciences, The University of Montana, 32 Campus Drive #1552, Missoula, Montana 59812-1552, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|